Skip to content
Screener

Tvardi Therapeutics TVRD Q1 2026 Annual earnings

Reported May 8, 2026 · Before market open

EPS-$0.73Miss by $0.08
EPS estimate-$0.65

Next report

Date not yet announced

FAQ

When did Tvardi Therapeutics report Q1 2026 earnings?
Tvardi Therapeutics (TVRD) reported Q1 2026 earnings on May 8, 2026 before market open.
What were Tvardi Therapeutics's Q1 2026 revenue and EPS?
Tvardi Therapeutics reported eps of $-0.73 for Q1 2026.
Did Tvardi Therapeutics beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.65 by $0.08.
How did Tvardi Therapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 77.3% from $-3.22.
Where can I find Tvardi Therapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-057524) and the 10-K periodic report (0001104659-26-037729) directly on SEC EDGAR. The filing index links above go to sec.gov.